financetom
Business
financetom
/
Business
/
Sealed Air Agrees To $10.3 Billion Takeover By CD&R Funds
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sealed Air Agrees To $10.3 Billion Takeover By CD&R Funds
Nov 17, 2025 8:43 AM

Sealed Air Corporation ( SEE ) shares are trading lower on Monday following the company’s agreement to be acquired by funds affiliated with CD&R in an all-cash deal valuing the business at $10.3 billion.

Details

As per the deal, shareholders will receive $42.15 per share in cash, reflecting a 41% premium to Sealed Air's ( SEE ) closing price on August 14, 2025.

The purchase price also represents a 24% premium to the company's 90-day VWAP as of November 12, 2025.

Sealed Air ( SEE ) will have a 30-day go-shop period to seek alternative acquisition offers, plus 15 additional days to negotiate a binding agreement with any qualifying bidder.

The transaction, expected to close in mid-2026, has been unanimously approved by Sealed Air’s Board of Directors.

Management Commentary

“This transaction delivers significant and derisked value to Sealed Air ( SEE ) stockholders while accelerating our ongoing transformation,” said Dustin Semach, president and CEO of Sealed Air ( SEE ). “CD&R’s partnership will enhance our ability to invest in growing our Food and Protective businesses while maintaining a customer-first approach.”

Recent Earnings Release

This month, Sealed Air ( SEE ) posted third-quarter adjusted EPS of $0.87, topping the $0.70 estimate, and revenue of $1.35 billion also beat expectations of $1.31 billion.

The company raised FY25 adjusted EPS guidance to $3.25–$3.35 (from $2.90–$3.30) versus the $3.17 consensus, and tightened its FY25 revenue outlook to $5.275–$5.325 billion (from $5.1–$5.5 billion), versus $5.292 billion estimate.

Price Action: SEE shares are down 3.37% at $41.83 at the last check on Monday.

Read Next:

Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RBC Previews This Week's International Merchandise Trade in Canada
RBC Previews This Week's International Merchandise Trade in Canada
Dec 2, 2024
06:56 AM EST, 12/02/2024 (MT Newswires) -- RBC said it expects that the Canadian trade deficit narrowed to C$300 million in October from C$1.3 billion in September, mainly driven by higher exports. Oil prices rose in October, pushing up the energy trade balance, noted the bank. Canada is slated to release its October international merchandise trade figures on Thursday, at...
Northern Star Acquires De Grey For $3.3 Billion, Secures Promising Tier 1 Asset
Northern Star Acquires De Grey For $3.3 Billion, Secures Promising Tier 1 Asset
Dec 2, 2024
Leading Australian gold miner Northern Star Resources (OTC:NSTYY) has announced a $3.3 billion acquisition of De Grey Mining ( DGMLF ) , taking over De Grey's prized Hemi gold project. This acquisition reinforces Northern Star's position as the leading ASX-listed gold company and a top-ten global gold producer, stated Stuart Tonkin, CEO of Northern Star. The Hemi project is a...
Australia Proposes Fines of up to $33 Million for Tech Firms Over Anti-Competitive Practices
Australia Proposes Fines of up to $33 Million for Tech Firms Over Anti-Competitive Practices
Dec 2, 2024
06:58 AM EST, 12/02/2024 (MT Newswires) -- Apple ( AAPL ) , Google ( GOOG ) , and Meta (META) could face fines of up to 50 million Australian dollars ($33 million) under a proposed law in Australia aimed at curbing anti-competitive practices in the digital economy, Reuters reported on Monday. The legislation, if enacted, would grant the government the...
Novocure's pancreatic cancer treatment meets main goal in late-stage study
Novocure's pancreatic cancer treatment meets main goal in late-stage study
Dec 2, 2024
Dec 2 (Reuters) - Novocure ( NVCR ) said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy, achieving the primary goal in a late-stage trial. The therapy uses Tumor Treating Fields, or electric fields, to kill cancer cells while sparing most nearby healthy cells, using a portable...
Copyright 2023-2026 - www.financetom.com All Rights Reserved